Effects of losartan on the mobilization of endothelial progenitor cells and improvement of endothelial function

Annals of Clinical and Laboratory Science

Volumn 43, Issue 4, 2013, Pages 402-406

  Tan, Hong ^a   Li, Xiaoyan ^a   Chen, Wei ^b   Chen, Yingjian ^a   Wei, Xiuying ^a   Yang, Yan ^a   Zhang, Hongming ^a   Jin, Qun ^a  

^a General Hospital of Ji'nan Military Region   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Blood flow mediated endothelium dependent function (FMD); Coronary artery disease (CHD); Endothelial progenitor cell (EPCs); Losartan

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; ISOSORBIDE MONONITRATE; LOSARTAN; SIMVASTATIN; TRIMETAZIDINE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD FLOW; BRACHIAL ARTERY; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM; EVENING DOSAGE; FEMALE; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STEM CELL MOBILIZATION; AGED; ANALYSIS OF VARIANCE; CHINA; CORONARY DISEASE; DRUG EFFECTS; ENDOTHELIUM CELL; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; STEM CELL;

AGED; ANALYSIS OF VARIANCE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BRACHIAL ARTERY; CHINA; CORONARY DISEASE; ENDOTHELIAL CELLS; FEMALE; HUMANS; LOSARTAN; MALE; MIDDLE AGED; STEM CELLS;

EID: 84889038419     PISSN: 00917370     EISSN: 15508080     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Garcia MM, Lima PR, Correia LC: Prognostic value of endothelial function in patients with atherosclerosis: systematic review. Arquivos brasileiros de cardiologia 2012.
2. Kulbertus H, Lancellotti P: [Atherosclerosis: a complex disease]. Revue medicale de Liege 2012;67(5-6):273-278.
3. Vanhoutte PM: Endothelial dysfunction: the first step toward coronary arteriosclerosis. Circ J 2009;73(4):595-601.
4. Cozzolino M, Ketteler M, Zehnder D: The vitamin D system: a crosstalk between the heart and kidney. European journal of heart failure 2010;12(10):1031-1041.
5. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340(8828):1111-1115.
6. Murohara T: Therapeutic vasculogenesis using human cord blood-derived endothelial progenitors. Trends in cardiovascular medicine 2001;11(8):303-307.
7. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM: Isolation of putative progenitor endothelial cells for angiogenesis. Science (New York, NY) 1997;275(5302):964-967.
8. Suda T, Takakura N, Oike Y: Hematopoiesis and angiogenesis. International journal of hematology 2000;71(2):99-107.
9. George J, Herz I, Goldstein E, Abashidze S, Deutch V, Finkelstein A, Michowitz Y, Miller H, Keren G: Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. Arteriosclerosis, thrombosis, and vascular biology 2003;23(12):e57-60.
10. Kipshidze N, Dangas G, Tsapenko M, Moses J, Leon MB, Kutryk M, Serruys P: Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. Journal of the American College of Cardiology 2004;44(4):733-739.
11. Werner N, Junk S, Laufs U, Link A, Walenta K, Bohm M, Nickenig G: Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circulation research 2003;93(2):e17-24.
12. Yu Y, Fukuda N, Yao EH, Matsumoto T, Kobayashi N, Suzuki R, Tahira Y, Ueno T, Matsumoto K: Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension. American journal of hypertension 2008;21(1):72-77.
13. Yu Y, Wang Y, Zhou LN, Zheng F: ARB treatment prevents the decrease in endothelial progenitor cells and the loss of renal microvasculature in remnant kidney. American journal of nephrology 2011;33(6):550-557.
14. Yao EH, Fukuda N, Matsumoto T, Kobayashi N, Katakawa M, Yamamoto C, Tsunemi A, Suzuki R, Ueno T, Matsumoto K: Losartan improves the impaired function of endothelial progenitor cells in hypertension via an antioxidant effect. Hypertens Res 2007;30(11):1119-1128.
15. Bae JH, Bassenge E, Kim KB, Kim YN, Kim KS, Lee HJ, Moon KC, Lee MS, Park KY, Schwemmer M: Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress. Atherosclerosis 2001;155(2):517-523.
16. Bartnik M, Ryden L, Ferrari R, Malmberg K, Pyorala K, Simoons M, Standl E, Soler-Soler J, Ohrvik J: The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. European heart journal 2004;25(21):1880-1890.
17. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. The New England journal of medicine 2003;348(7):593-600.
18. Chironi G, Walch L, Pernollet MG, Gariepy J, Levenson J, Rendu F, Simon A: Decreased number of circulating CD34+KDR+ cells in asymptomatic subjects with preclinical atherosclerosis. Atherosclerosis 2007;191(1):115-120.
19. Fadini GP, Baesso I, Albiero M, Sartore S, Agostini C, Avogaro A: Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis 2008;197(2):496-503.
20. Pirro M, Schillaci G, Bagaglia F, Menecali C, Paltriccia R, Mannarino MR, Capanni M, Velardi A, Mannarino E: Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk. Atherosclerosis 2008;197(2):757-767.
21. Matsuura K, Hagiwara N: The pleiotropic effects of ARB in vascular endothelial progenitor cells. Current vascular pharmacology 2011;9(2):153-157.